Insulin-like growth factor-1 mRNA isoforms and insulin-like growth factor-1 receptor mRNA expression in chronic hepatitis C

Figure 1 Shares (%) of studied insulin-like growth factor-1 mRNA isoforms of class 1 (I) and class 2 (II) (depending upon employed promoter P1 or P2) as related to the total mRNA for both insulin-like growth factor-1 promoters (100%) in chronic hepatitis C patients and in the control. IGF: Insulin-like growth factor; CH-C: Chronic hepatitis C.

Figure 2 Shares (%) of splicing mRNA isoforms for insulin-like growth factor-1 (1A, 1B, 1C) as related to the total amount of mRNA for all three insulin-like growth factor-1 isoforms (100%) in chronic hepatitis C patients and in the control. IGF: Insulin-like growth factor; CH-C: Chronic hepatitis C.

Figure 3 Comparison of shares (%) in expression of insulin-like growth factor-1 mRNA isoforms in patients chronically infected with hepatitis C virus and in the control. ^bP < 0.01 vs control.